ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Gm2a Regulates Memory Cd8+ T Cell Activation and Differentiation

K. P. Tong1, K. M. Baecher2, C. R. Hartigan1, M. Ford3

1Emory University Transplant Center, Emory University, Atlanta, GA, 2Department of Surgery, Emory University, Atlanta, GA, 3Emory University, Atlanta, GA

Meeting: 2022 American Transplant Congress

Abstract number: 928

Keywords: knockout, T cell reactivity, T cells

Topic: Basic Science » Basic Science » 09 - Signaling and Co-Stimulation

Session Information

Session Name: Co-Stimulation in Alloreactive Effector and Regulatory Responses

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: In a clinical trial, patients who underwent kidney transplantation and were subsequently stable off tacrolimus immunosuppression exhibited increased Gm2a transcript in PBMC relative to patients who experienced rejection. While Gm2a, a lipid transfer protein that stimulates the enzymatic processing of gangliosides, is well known to contribute to sphingolipid metabolism in neurologic disorders, its role in the immune system has not been well-investigated. In a mouse model, we found that mice lacking Gm2a exhibit accelerated allograft rejection and exhibited enhanced alloreactive CD8+ T cell responses compared to WT mice. However, the role of Gm2a in memory T cell responses is unknown. Because memory T cells can play a significant role in mediating breakthrough rejection in the presence of immunosuppression, here we endeavored to determine the impact of Gm2a deficiency on naïve vs. memory CD8+ T cells.

*Methods: An in vitro culture system in which splenocytes from WT and Gm2a-/- mice that express the OT-I T cell receptor specific for OVA257-264 were stimulated for 4 days with OVA257-264 peptide to generate effector/memory CD8+ T cells was established. On day 4, WT and Gm2a-/- effector/ memory CD8+ T cells were restimulated for 4 hours again with OVA257-264 peptide. In addition, naïve WT and Gm2a-/- OT-I T cells were also stimulated for 4 hours with OVA257-264 peptide. The expression of T cell activation markers on both naïve and memory WT vs. Gm2a-/- T cells was assessed via flow cytometry.

*Results: Results indicated that Gm2a-/- memory CD8+ T cells exhibited significantly increased expression of CD44 (p < 0.0001) and CD25 (p < 0.0001) relative to WT memory CD8+ T cells following a short in vitro restimulation. These differences were more pronounced on memory CD8+ T cells relative to naïve CD8+ T cells. In naïve cells stimulated with a range of 1 pM to 100 µM OVA257-264, we found that a marker of early activation (CD69) began increasing at lower OVA257-264 concentrations in Gm2a-/- vs. WT cells. These results demonstrate that Gm2a deficiency impacts memory CD8+ T cells in addition to naïve CD8+ T cells.

*Conclusions: These results show that Gm2a-/- memory CD8+ T cells express significantly more of the high affinity IL-2R relative to WT memory CD8+ T cells, a finding which may underlie their increased proliferation and accumulation in vivo. Overall, these findings suggest that increasing Gm2a activity could be a potential immunotherapeutic strategy to modulate memory CD8+ T cell alloreactivity during transplantation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Tong KP, Baecher KM, Hartigan CR, Ford M. Gm2a Regulates Memory Cd8+ T Cell Activation and Differentiation [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/gm2a-regulates-memory-cd8-t-cell-activation-and-differentiation/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences